These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8464231)

  • 1. Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis.
    Knulst AC; Adriaansen HJ; Hählen K; Stigter JC; van den Beemd MW; Hagemeijer A; van Dongen JJ; Hooijkaas H
    Leukemia; 1993 Apr; 7(4):532-6. PubMed ID: 8464231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias.
    Consolini R; Scamardella F; Legitimo A; Putti C; Granchi D; Paolucci P; Lippi A; Guazzelli C; Acquaviva A; Rosanda C
    Haematologica; 1993; 78(5):297-305. PubMed ID: 8314159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
    Smedmyr B; Bengtsson M; Jakobsson A; Simonsson B; Oberg G; Tötterman TH
    Eur J Haematol; 1991 Mar; 46(3):146-51. PubMed ID: 1826271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
    Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
    Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
    Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
    Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
    Maitra A; McKenna RW; Weinberg AG; Schneider NR; Kroft SH
    Am J Clin Pathol; 2001 Jun; 115(6):868-75. PubMed ID: 11392884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)].
    Welte K; Ebener U; Hinderfeld L; Ritter J; Henze G; Kornhuber B
    Klin Padiatr; 1981 May; 193(3):165-71. PubMed ID: 6943391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
    Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
    Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal studies after bone marrow transplantation for leukaemia in children.
    van den Berg H; Beverstock G; Westerhof JP; Vossen JM
    Bone Marrow Transplant; 1991 May; 7(5):335-42. PubMed ID: 2070142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
    Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
    Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression.
    Lavabre-Bertrand T; Janossy G; Ivory K; Peters R; Secker-Walker L; Porwit-MacDonald A
    Cytometry; 1994 Dec; 18(4):209-17. PubMed ID: 7895527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
    Klujber V; Koós R; Schuler D; Bocsi J
    Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
    Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
    Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow cellularity in acute lymphoblastic leukemia of children].
    Styczyński J; Kubicka M; Langer B; Wysocki M; Debski R; Wolska E; Polańska M
    Wiad Lek; 2000; 53(9-10):507-12. PubMed ID: 11148917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.